ACH vs PATH
Accendra Health Inc (ACH) versus Uipath Inc (PATH) — a side-by-side from cached financials, not a winner call.
Accendra Health Inc (ACH) is a medical distribution company listed on NYSE.
Uipath Inc (PATH) is a software - infrastructure company listed on US.
Latest reported ACH revenue for 2024-12-31 was $10.70B. Net income was -$362.7M. Revenue was up 3.6% from 2023-12-31 to 2024-12-31. ACH currently screens at market cap $237.8M.
Latest reported PATH revenue for 2026-01-31 was $1.61B. Net income was $282.3M. Revenue was up 12.7% from 2025-01-31 to 2026-01-31. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
ACH currently screens at market cap $237.8M. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
Not investment advice. Open the ACH and PATH stock pages for the full models.
Not investment advice.